Trial intelligence / Profile preview

PEGASYS Plus COPEGUS in Iranian Hemophilic Patients With Chronic Hepatitis C

NCT00707772Phase 4Completed

Sponsor
Baqiyatallah University of Medical Sciences
Start
Mar 2007
Primary completion
Sep 2009
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of peginterferon alfa-2a, ribavirin in hepatitis C (HCV), sponsored by Baqiyatallah University of Medical Sciences. Started Mar 2007; status: completed.

02

Drugs

peginterferon alfa-2aribavirin
03

Conditions

hepatitis C (HCV)

Beyond the preview

Go deeper on NCT00707772.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00707772.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call